ASP Isotopes (NASDAQ:ASPI) CFO Heather Kiessling Sells 21,830 Shares of Company Stock

ASP Isotopes Inc. (NASDAQ:ASPI) CFO Heather Kiessling sold 21,830 shares of the business’s stock in a transaction that occurred on Friday, October 16th. The shares were sold at an average price of $2.19, for a total transaction of $47,807.70. Following the completion of the transaction, the chief financial officer directly owned 1,504,422 shares of the company’s stock, valued at approximately $3,294,684.18. This represents a 1.43% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

ASP Isotopes Stock Performance

Shares of ASPI opened at $2.17 on Thursday. ASP Isotopes Inc. has a 1 year low of $1.89 and a 1 year high of $11.22. The company’s 50 day simple moving average is $3.26 and its 200 day simple moving average is $4.68. The company has a market capitalization of $332.68 million, a price-to-earnings ratio of -1.64 and a beta of 3.69. The company has a debt-to-equity ratio of 0.76, a quick ratio of 3.85 and a current ratio of 3.87.

ASP Isotopes (NASDAQ:ASPI) last released its earnings results on Friday, August 14th. The company reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.17) by ($0.11). The firm had revenue of $5.12 million during the quarter, compared to analysts’ expectations of $4.47 million. ASP Isotopes had a negative return on equity of 64.99% and a negative net margin of 427.98%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on ASPI shares. Wall Street Zen raised ASP Isotopes from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 22nd. Weiss Ratings reiterated a “sell (d-)” rating on shares of ASP Isotopes in a research report on Monday, September 21st. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat.com, ASP Isotopes has a consensus rating of “Hold” and an average price target of $13.00.

Institutional Investors Weigh In On ASP Isotopes

Several hedge funds have recently modified their holdings of ASPI. The Manufacturers Life Insurance Company boosted its position in shares of ASP Isotopes by 8.8% in the first quarter. The Manufacturers Life Insurance Company now owns 30,503 shares of the company’s stock worth $135,000 after acquiring an additional 2,470 shares during the last quarter. Sanctuary Advisors LLC grew its holdings in ASP Isotopes by 22.2% in the first quarter. Sanctuary Advisors LLC now owns 24,615 shares of the company’s stock valued at $109,000 after purchasing an additional 4,465 shares during the period. Royal Bank of Canada increased its position in ASP Isotopes by 18.4% during the first quarter. Royal Bank of Canada now owns 37,954 shares of the company’s stock worth $167,000 after purchasing an additional 5,906 shares during the last quarter. State of Wyoming acquired a new position in ASP Isotopes during the first quarter worth approximately $29,000. Finally, Allworth Financial LP acquired a new position in ASP Isotopes during the second quarter worth approximately $51,000. 16.80% of the stock is owned by institutional investors and hedge funds.

ASP Isotopes Company Profile

ASP Isotopes Inc (NASDAQ: ASPI) is a development-stage advanced materials company focused on isotope enrichment. The company is developing proprietary technology intended to separate and enrich isotopes for use in several high-value markets, including nuclear energy, medicine, semiconductors, quantum computing and other industrial applications.

ASP Isotopes has described its platform as being designed to provide more efficient and scalable isotope production than certain conventional enrichment methods.